The leading microbiome company in oncology

We are a clinical-stage microbiome therapeutics company
aiming to improve survival in cancer.

Our strengths

A full ecosystem approach

Oncology focused

AI-Powered Drug Development

cGMP Versatile Manufacturing Capacities

Latest News

July 5, 2024

July 5, 2024: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

July 5, 2024

July 5, 2024: MaaT Pharma: Half-year Report and an Increase of the Resources Allocated to the Liquidity Contract With Kepler Cheuvreux

July 2, 2024

July 2, 2024: MaaT Pharma Announces First DSMB Positive Review of Ongoing Phase 2 Clinical Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT

Like what you see? See more posts

Our upcoming events

Event
June 11, 2024

Portzamparc Mid & Small Caps 2024 Conference

• June 11-12, 2024 – Portzamparc Mid & Small Caps 2024 Conference
MaaT Pharma
Event
June 11, 2024

IHMC 2024

• June 22-25, 2024 – International Human Microbiome Consortium (IHMC) Congress 2024
MaaT Pharma
Event
June 10, 2024

Stifel European Healthcare Summit Lyon

June 25-27, 2024 – Stifel European Healthcare Summit Lyon
MaaT Pharma

Join the MaaT Pharma adventure!

Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.

Learn more about our values, our environment and see what we have to offer to you!

Careers